Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 58 | 59 | 65 | 23 | 13 | 36 | 34 | 49 | 63 | 101 | 62 | 44 | 26 |
Research, Review articles and Editorials |
2 | 4 | 1 | 2 | 12 | 12 | 29 | 28 | 44 | 56 | 80 | 48 | 12 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 54 | 58 | 63 | 11 | 1 | 7 | 6 | 5 | 7 | 21 | 14 | 32 | 6 |
Conference proceedings |
0 | 40 | 12 | 37 | 0 | 0 | 145 | 138 | 95 | 63 | 154 | 72 | 54 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
522 | 678 | 761 | 838 | 697 | 626 | 613 | 599 | 538 | 478 | 262 | 142 | 31 | 69 |
Journal total citations count | 6793 |
Journal impact factor | 1.64 |
Journal 5 years impact factor | 1.70 |
Journal cite score | 11.56 |
Journal h-index | 33 |
Parsons XH (2013) The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol 1: 02.
Parsons XH (2014) The openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2: 20114.
Kallas A, Pook M, Trei A, Maimets T (2014) Assessment of the potential of CDK2 inhibitor NU6140 to influence the expression of pluripotency markers NANOG, OCT4, and SOX2 in 2102Ep and H9 cells. International journal of cell biology.
Parsons XH (2013) Exploring future cardiovascular medicine: heart precursors directed from human embryonic stem cells for myocardium regeneration. Cardiovascular Pharmacology: Open Access.
Pourrajab F, Zarch MB, BaghiYazdi M, Hekmatimoghaddam S, Zare-Khormizi MR (2014) MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation. The international journal of biochemistry & cell biology 55: 318-328.
Wang T, Shi SB, Sha HY (2013) MicroRNAs in regulation of pluripotency and somatic cell reprogramming: small molecule with big impact. RNA biology 10:1255-1261.
Rogler CE, Bebawee R, Matarlo J, Locker J, Pattamanuch N, et al. (2016) Triple Staining Including FOXA2 Identifies Stem Cell Lineages Undergoing Hepatic and Biliary Differentiation in Cirrhotic Human Liver. Journal of Histochemistry & Cytochemistry.
Mehdizadeh A, Darabi M (2017) Reprogrammed Cellâ€based Therapy for Liver Disease: From Lab to Clinic. Journal of Renal and Hepatic Disorders 1: 20-28.
SALAMH ME, MEHANNA RA, HANAFY SM, GHAFFAR HA. THE USAGE OF LIVER EXTRACT VERSES GROWTH FACTORS IN THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS INTO HEPATOCYTE LIKE CELLS.
Roy-Chowdhury N, Wang X, Guha C, Roy-Chowdhury J (2017) Hepatocyte-like cells derived from induced pluripotent stem cells. Hepatology International 11: 54-69.
Sauer V, Roy-Chowdhury N, Guha C, Roy-Chowdhury J (2014) Induced pluripotent stem cells as a source of hepatocytes. Current pathobiology reports 2: 11-20.
Cai Y, Xu L, Xu H, Fan X (2016) SIRT1 and neural cell fate determination. Molecular neurobiology 53: 2815-2825.
Siller R, Greenhough S, Naumovska E, Sullivan GJ (2015) Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem cell reports 4: 939-952.
Parsons XH (2013) Cellular medicine for the heart-the pharmacologic utility and capacity of human cardiac stem cells. J Clin Exp Cardiolog S. 11: 2.
Gerbal-Chaloin S, Funakoshi N, Caillaud A, Gondeau C, Champon B, Si-Tayeb K (2014) Human induced pluripotent stem cells in hepatology: beyond the proof of concept. The American journal of pathology 184: 332-347.
Goldman O, Han S, Sourrisseau M, Dziedzic N, Hamou W, et al. (2013) KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development. Cell stem cell 12: 748-760.
Parsons XH (2013) Reviving cell-based regenerative medicine for heart reconstitution with efficiency in deriving cardiac elements from pluripotent human embryonic stem cells. Cardiovascular Pharmacology: Open Access.
Malhi R, Patthi B, Singla A, Singh S, Pandita V, et al. Dental pluripotent cells-a promise for tissue regeneration.
Parsons XH (2016) Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. Human Embryonic Stem Cell Protocols 299-318.
Hisham Zainal Ariffin S, Manogaran T, Zarina Zainol Abidin I, Megat Abdul Wahab R, Senafi S (2017) A Perspective on Stem Cells as Biological Systems that Produce Differentiated Osteoblasts and Odontoblasts. Current Stem Cell Research & Therapy 12: 247-259.